Literature DB >> 7638987

Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells.

G M Halliday1, A Patel, M J Hunt, F J Tefany, R S Barnetson.   

Abstract

Spontaneous regression occurs in some human malignant melanomas and basal cell carcinomas (BCCs). We have compared the cellular infiltrate in regressing and nonregressing tumors in order to analyze the mechanism by which regression occurs. Regressing primary melanomas and BCCs were infiltrated with a larger number of CD4+, but not CD8+, T lymphocytes than were seen in nonregressing tumors. The number of interleukin 2 receptor-positive (early activation marker) but not transferrin receptor-positive (intermediate activation marker) T cells was increased, indicating that the infiltrating T cells were activated. Large numbers of Langerhans cells, macrophages, and other class II major histocompatibility complex (MHC)-expressing cells were present but were not increased in the regressing tumors. There were no detectable B lymphocytes, and the regressing tumor cells displayed levels of HLA-DR expression similar to those of the nonregressing tumors. Comparison of squamous cell carcinoma (SCCs) with keratoacanthomas (KAs), which are likely to be a spontaneously regressing form of SCC, also showed increased infiltration of activated CD4+, but not CD8+, T cells within the KA. A murine ultraviolet (UV)-induced squamous tumor that spontaneously regresses when transplanted into immunocompetent syngeneic mice was also infiltrated with increased numbers of activated CD4+, but not CD8+, T cells prior to and during rejection. These results indicate that spontaneous regression of human skin tumors is likely to be immunologically mediated, and that CD4+ T lymphocytes seem to mediate this regression.

Entities:  

Mesh:

Year:  1995        PMID: 7638987     DOI: 10.1007/bf00299157

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  41 in total

1.  DNA image cytometry of keratoacanthoma and squamous cell carcinoma.

Authors:  A J Herzberg; B J Kerns; S V Pollack; R B Kinney
Journal:  J Invest Dermatol       Date:  1991-09       Impact factor: 8.551

2.  Epidermal keratinocytes express the adhesion molecule intercellular adhesion molecule-1 in inflammatory dermatoses.

Authors:  K H Singer; D T Tuck; H A Sampson; R P Hall
Journal:  J Invest Dermatol       Date:  1989-05       Impact factor: 8.551

3.  Lysis of human keratinocytes by allogeneic HLA class I-specific cytotoxic T cells. Keratinocyte ICAM-1 (CD54) and T cell LFA-1 (CD11a/CD18) mediate enhanced lysis of IFN-gamma-treated keratinocytes.

Authors:  F W Symington; E B Santos
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

4.  Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma.

Authors:  F J Tefany; R S Barnetson; G M Halliday; S W McCarthy; W H McCarthy
Journal:  J Invest Dermatol       Date:  1991-08       Impact factor: 8.551

5.  Tumor antigen presentation by murine epidermal cells.

Authors:  S Grabbe; S Bruvers; R L Gallo; T L Knisely; R Nazareno; R D Granstein
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

6.  Immunogenicity and cross-reactivity of syngeneic murine melanomas.

Authors:  C Donawho; M L Kripke
Journal:  Cancer Commun       Date:  1990

7.  Cyclosporine in atopic dermatitis. Modulation in the expression of immunologic markers in lesional skin.

Authors:  T van Joost; M M Kozel; B Tank; R Troost; E P Prens
Journal:  J Am Acad Dermatol       Date:  1992-12       Impact factor: 11.527

8.  Biologic behavior of thin malignant melanomas with regressive changes.

Authors:  R R Paladugu; R H Yonemoto
Journal:  Arch Surg       Date:  1983-01

9.  Expression of OKM5 antigen on human keratinocytes in vitro upon stimulation with gamma-interferon.

Authors:  J Hunyadi; M Simon
Journal:  Acta Derm Venereol       Date:  1986       Impact factor: 4.437

10.  A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

Authors:  C Traversari; P van der Bruggen; I F Luescher; C Lurquin; P Chomez; A Van Pel; E De Plaen; A Amar-Costesec; T Boon
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  32 in total

Review 1.  New treatments for metastatic melanoma.

Authors:  Craig Gedye; David Hogg; Marcus Butler; Anthony M Joshua
Journal:  CMAJ       Date:  2014-02-18       Impact factor: 8.262

2.  Gastrointestinal bleeding as the first manifestation of a burned-out tumour of the testis.

Authors:  Cecilia Castillo; Gabriel Krygier; Julio Carzoglio; Raúl Cepellini Magariños; Raúl Cepellini Olmos; Juan Jubín; Graciela Sabini
Journal:  Clin Transl Oncol       Date:  2005-11       Impact factor: 3.405

3.  'The nodule that disappeared' spontaneous regression of an eyelid noduloulcerative lesion mimicking the features of a basal cell carcinoma.

Authors:  Tafadzwa Young-Zvandasara; Magdalena Popiela; Garry Shuttleworth
Journal:  BMJ Case Rep       Date:  2015-01-29

Review 4.  Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy.

Authors:  Akshata Udyavar; Terrence L Geiger
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-08-01       Impact factor: 4.291

5.  Progressor but not regressor skin tumours inhibit Langerhans' cell migration from epidermis to local lymph nodes.

Authors:  A D Lucas; G M Halliday
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

6.  Chronic stress and susceptibility to skin cancer.

Authors:  Alison N Saul; Tatiana M Oberyszyn; Christine Daugherty; Donna Kusewitt; Susie Jones; Scott Jewell; William B Malarkey; Amy Lehman; Stanley Lemeshow; Firdaus S Dhabhar
Journal:  J Natl Cancer Inst       Date:  2005-12-07       Impact factor: 13.506

Review 7.  Immune surveillance of tumors.

Authors:  Jeremy B Swann; Mark J Smyth
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  Characterization of three newly established rat sarcoma cell clones.

Authors:  Monika Holubova; Martin Leba; Markéta Sedmikova; Luca Vannucci; Vratislav Horak
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-11-13       Impact factor: 2.416

9.  Short-term stress enhances cellular immunity and increases early resistance to squamous cell carcinoma.

Authors:  Firdaus S Dhabhar; Alison N Saul; Christine Daugherty; Tyson H Holmes; Donna M Bouley; Tatiana M Oberyszyn
Journal:  Brain Behav Immun       Date:  2009-09-16       Impact factor: 7.217

10.  The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma.

Authors:  Nicole M Rochet; Lisa A Kottschade; Travis E Grotz; Luis F Porrata; Svetomir N Markovic
Journal:  Am J Clin Oncol       Date:  2015-06       Impact factor: 2.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.